The present invention is directed to a method and pharmaceuticals for
treating HIV and secondary infection. One aspect of this invention
involves the use of one or more polypeptides with an amino acid sequence
including KPV, MEHFRWG, HFRWGKPV, or SYSMEHFRWGKPV for treatment of HIV.
HIV is accompanied by infections, inflammation or both. In one preferred
embodiment of the invention, the one or more polypeptides are used for
treatment of HIV itself via medication taken orally or parentally. In
another preferred embodiment of the invention, the treatment is for
secondary infections arising from Staphylococcus aureus and Candidia
albicans and can be taken either orally or parentally. In another
preferred embodiment of the invention, treatment is carried out by local
application of the polypeptides through a carrier onto the site of S.
aureus or C. albicans infection.
